(Q65351039)

English

Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease

clinical trial

Statements

CATS29 (English)
0 references
A Phase IIb, Multicentre, Randomised, Double-blinded, Placebo-controlled, Multi-dose and Multi-injection, Parallel Groups Study to Evaluate the Efficacy and the Safety of Ovasave in Patients With Active Refractory Crohn's Disease (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
December 2014
0 references
November 2016
0 references
32
0 references
18 year
0 references
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit